BioConsortia, a Davis, California-based agricultural biotechnology company, raised an additional $15m in Series B funding.
Khosla Ventures and Otter Capital participated equally in the round.
The company intends to use the funds to accelerate plans to commercialize the use of microbial consortia as seed treatments and soil additive and to build collaborative partnerships with seed, fertilizer and crop production companies.
Led by CEO Marcus Meadows-Smith, BioConsortia uses a proprietary method for the selection of beneficial microbial consortia for crop improvement with no genetic modification required.
The company has pipeline products and research projects for enhanced utilization and substitution of N, P, K and S fertilizers. plant growth improvement including harvestable yield, root mass and accelerated development and other desirable crop traits such as abiotic tolerance, biotic resistance and enhanced metabolite expression.
FinSMEs
07/04/2014